Sage Therapeutics

Developer of drug candidates for the treatment of rare CNS disorders

placeBoston, Massachusetts, United States calendar_todayFounded 1971 groups487 employees language sagerx.com

Social engagement

Social engagement: 114.5K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Orbimed, Foresite Capital, EcoR1.

Investor typeCountShare
Venture capital538%
Private equity323%
Other / undisclosed538%

Recent activity

13 Feb 2026
Partnership
Sage Therapeutics
Coming soon